Allergan will pay $600 million for its marketing tactics while the F.D.A. decides on the drug’s use for migraines.

Sweet and seared flavors combine in an Asian version of the American classic.

A huge private donation for a cancer center could lure talent to an overlooked nation.

The magazine published ratings of 221 heart bypass surgical groups from 42 states online on Tuesday and will print them in its October issue.

The two companies agreed in January to jointly develop ZymoGenetics’s hepatitis C drug and share the profits.

A federal judge refused to lift a ban on federal funding of human embryonic stem cell research.

An American psychiatrist’s program of techniques to reduce stress has helped people in Gaza and Israel deal with the effects of violence.

Psychologists have discovered that some of the most hallowed advice on study habits is flat wrong.

Everyone is exposed to BPA, but after hundreds of studies, there is no consensus about its safety.

A heavy reliance on emergency rooms care is seen as a sign of weaknesses in the primary health care system.